|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
Synopsis for September 21, 2001
MMWR articles are embargoed until 4 p.m., ET, Thursdays.
- Shigellosis Outbreak Associated with an Unchlorinated Fill-and-Drain Wading Pool Iowa, 2001
- Resistance of Streptococcus pneumoniae to Fluoroquinolones United States, 19951999
- Weekly Update: West Nile Virus Activity United States, September 11-18, 2001
Notice to Readers
FDA Approval for a Combined Hepatitis A and Hepatitis B Vaccine
The Food and Drug Administration has licensed a combined hepatitis A and hepatitis B vaccine (TwinrixŽ) for use among persons 18 years of
age and older. The antigenic components in TwinrixŽ have been used routinely in separate single antigen vaccines in the United States since
1995 and 1989.
Contact: Office of Communication
CDC, Media Relations Division
(404) 6393286
Synopsis for September 21, 2001
Shigellosis Outbreak Associated with an Unchlorinated Fill-and-Drain Wading Pool Iowa, 2001
Outbreaks of illness associated with recreational water use have increased in recent years.
PRESS CONTACT:
Office of Communication
CDC, Media Relations Division
(404) 6393286 |
|
Although outbreaks of recreational water illness have been increasing over the past decade, many of these outbreaks can be prevented. Bacterial
outbreaks, such as reported from Iowa, should not occur if aquatic facilities are disinfected and pool water quality is maintained
appropriately. In this outbreak the wading pool was unchlorinated and was frequented by diaper- and toddler-aged children who may be more likely
to be infected with Shigella. Shigellosis is caused by bacteria. Most people who are infected develop diarrhea, fever, and stomach
cramps starting a day or two after they are exposed. More information on recreational water illness can be found online at: www.cdc.gov/healthyswimming.
More information on Shigellosis is online at www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_g.htm.
Resistance of Streptococcus pneumoniae to Fluoroquinolones United States, 19951999
Fluoroquinolones are important agents for treating pneumococcal infections and community-acquired pneumonia.
PRESS CONTACT:
Office of Communication
CDC, Media Relations Division
(404) 6393286 |
|
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia, meningitis, and otitis media in the United States.
Because of the emergence of antimicrobial resistance in pneumococci, fluoroquinolones are now recommended by some groups for the treatment of
pneumonia in adults, especially when antibiotic-resistance is suspected. This report indicates that pneumococci with reduced susceptibility to
fluoroquinolones are appearing in the United States. Appropriate use of antibiotics is crucial for slowing emergence of fluoroquinolone
resistance. If fluoroquinolone resistance becomes more common, clinical laboratories should consider routine susceptibility testing of
fluoroquinolones on invasive pneumococcal isolates.
Weekly Update: West Nile Virus Activity United States, September 11-18, 2001
PRESS CONTACT:
Office of Communication
CDC, Media Relations Division
(404) 6393286 |
|
Beginning with this issue, the MMWR will feature timely updates of West Nile Virus (WNV) activities in the United States. The reports will
include information on human cases and deaths, infected birds and other animals, and WNV-positive mosquito pools.
|